British pharmaceutical giant GlaxoSmithKline (GSK) and Californian laboratory Vir Biotechnology on Tuesday announced final stage testing of their potential coronavirus treatment. The phase-three trials will evaluate the effectiveness of their “fully human anti-SARS-CoV-2 monoclonal antibody” VIR-7831 in the early treatment of patients at high risk of hospitalisation. If successful, the companies believe it could increase […]